The efficacy of orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC) associated with hepatitis C virus (HCV) is not well defined. This study examines the variables that may determine the outcome of OLT for HCC in HCV patients. From 1990 to 1999, 463 OLTs were performed for HCV c
Hepatitis C–associated hepatocellular carcinoma
✍ Scribed by Fuad Hasan; Lennox J. Jeffers; Maria De Medina; K. Rajender Reddy; Talley Parker; Eugene R. Schiff; Michael Houghton; Quilim Choo; George Kuo
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 342 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
It is known among liver specialists that hepatocellular carcinoma (HCC) among southern African blacks is quite different clinically as well as histopathologically from that in other ethnic g r o u p ~. l -~ As early as 1960, Steiner4 performed a pathological study on cirrhosis and HCC in sub-Saharan
## Abstract ## BACKGROUND. Chronic hepatitis C can result in fatty changes in the liver. Previous studies have suggested that hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus (HCV) infection. The authors sought to determine whether hepatic steatosi
## Abstract Etiological variations in hepatocellular carcinoma (HCC) exist across different geographic areas. To gain better control of HCC, we retrospectively studied the secular trends and geographic variations in hepatitis B virus (HBV)‐related and hepatitis C virus (HCV)‐related HCCs in Taiwan.
## Abstract Interleukin (IL)‐18 is a proinflammatory cytokine that is up‐regulated in patients with hepatitis C virus (HCV) infection, which is the most common underlying disease in hepatocellular carcinoma (HCC). The purpose of our study was to investigate the role of IL‐18 in HCC associated with